جست‌وجوی استاد و پژوهشگر

Chong Chun Wieمشاهده پروفایل

دانشیار

• Microbial Ecology
• Gut Microbiome Science
• Digital Health
• +۵ مورد دیگر

Chong Chun Wie is an Associate Professor and Deputy Head of School (Research) at the School of Pharmacy, Monash University Malaysia. He holds a BSc (HONS) in Biochemistry and a PhD in Microbial Ecology. His research focuses on microbial ecology, gut microbiome science, and digital health, addressing global challenges like diabetes prevention, antimicrobial resistance (AMR), and neurodegenerative disorders. He leads the Monash Microbiome Research Centre and co-leads the 1000MYMicrobiome Project. Dr. Chong has held roles including Program Director for the MSc Molecular Medicine program at International Medical University (IMU), securing accreditation for open distance learning, and establishing a double degree program with Queen Mary’s University of London. He is part of the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University Australia, ranked top 5 globally in QS rankings. His interdisciplinary work bridges microbiology, public health, and technology. Research interests include the gut-brain axis in neurological disorders, diet-microbiome-host metabolism interactions, and antibiotic effects on gut microbiota. Recent projects involve studying dietary impacts on gastrointestinal diseases and obesity via systems biology, and applying machine learning to analyze microbial interactions. He has also explored the microbiome of farm animals, preterm neonates, and links between gut health and diseases like Parkinson’s, diabetes, and oral cancer. Chong has secured grants for studies on probiotics, dietary fibers, and gut health interventions. His awards include the ITEX 2022 Gold Medal for contributions to digital health tools. He serves on editorial boards of journals like Therapeutic Advances in Gastroenterology and PLoS ONE . Key labs/teams: Monash Microbiome Research Centre, Future Centre Initiative at Monash University Malaysia. His work supports UN SDGs related to health, sustainable cities, and responsible consumption.

• Reproductive Medicine
• Microbiome Research
• Maternal and Neonatal Health
• +۳ مورد دیگر

Professor David MacIntyre is a Professor of Reproductive Systems Medicine and Director of the University of Adelaide's Robinson Research Institute. He also holds roles at Imperial College London as Section Head of Pregnancy, Parturition and Prematurity, and Co-Director of the March of Dimes Prematurity Research Centre. His research focuses on the microbiome's influence on reproductive health outcomes and developing clinical diagnostic tools for maternal and neonatal health. Education: PhD in Reproductive Medicine, University of Newcastle, Australia (2007) Postdoctoral training at Centro de Investigacion Principe Felipe, Spain Research interests include translational medicine, metabolic profiling, and global health collaborations. His work is supported by grants from the March of Dimes, UK MRC, Gates Foundation, and ERC, spanning partnerships in 12+ countries. Awards: Marie Curie Fellowship (Postdoc phase) UK MRC Career Development Award (2013) Grants & Collaborations: Focus on prematurity research, maternal health diagnostics, and microbiome applications. Active in international networks across Africa, Europe, Asia, and the Americas. Labs/Teams: Leads Robinson Research Institute's translational research programs and collaborates with Imperial College's Institute of Reproductive and Developmental Biology.

Pankaj Singhمشاهده پروفایل

پژوهشگر

• Microbial ecology
• Plant-microbe interactions
• Soil microbiome
• +۷ مورد دیگر

Pankaj Singh is a microbial ecologist and computational biologist at the University of Western Australia , affiliated with the School of Agriculture and Environment . His work focuses on plant-microbe interactions, soil microbiome dynamics, and ecosystem sustainability through multi-omics approaches. He holds a PhD in Microbial Ecology from Western Sydney University (2019–2024). Doctor of Philosophy, Western Sydney University His research expertise spans bioinformatics , transcriptomics , and soil biology , with applications in sustainable agriculture and climate resilience. Recent publications highlight his work on drought resistance mechanisms (2025), biochar for soil health (2025), and microbial community dynamics in Australian ecosystems (2024, 2023). Dr. Singh received the School Citizen Award (2024) and has conducted over 15 workshops globally, including two UWA workshops on R programming (2024) and microbiome analysis (2024). His work aligns with UN Sustainable Development Goals for agriculture, biotechnology, and environmental sustainability.

Mahmoud Ghannoumمشاهده پروفایل

استاد

• Medical Mycology
• Infectious Diseases
• Cancer Research
• +۶ مورد دیگر

Mahmoud Ghannoum, PhD, is a Professor in the Departments of Dermatology and Pathology at Case Western Reserve University School of Medicine, and Director of the Center for Medical Mycology at University Hospitals. His research focuses on fungal pathogens (e.g., Candida, Aspergillus, Cryptococcus) and their virulence factors, including biofilm formation and adhesion. He investigates the role of the bacteriome and mycobiome in cancer and inflammatory diseases like Crohn’s, emphasizing polymicrobial biofilms as potential drivers of colorectal cancer and gastrointestinal disorders. Dr. Ghannoum’s work spans microbial interactions, probiotic development for inflammation resolution, and antifungal resistance. He leads the Molecular Oncology Program at the Case Comprehensive Cancer Center, integrating microbiome research with oncology. His external roles include directing the Center for Medical Mycology, addressing fungal infections globally. Education: Advanced training in Medical Mycology. Research Interests: Fungal pathogenesis, microbiome-cancer interactions, probiotics, and antifungal therapies. Publications highlight his contributions to understanding fungal virulence, antimicrobial stewardship, and novel treatments for infections like onychomycosis and vulvovaginal candidiasis. His lab also explores microbiome modulation in chronic diseases, including autism and neuroendocrine tumors. Notable collaborations include studies on antibiotic resistance, gut-brain axis links, and probiotic formulations for inflammatory bowel disease. His research frequently addresses translational applications, bridging basic science and clinical practice.

Jan Roelof van der Meerمشاهده پروفایل

استاد

• Environmental microbiology
• Polluted ecosystems
• Bacterial adaptation and evolution
• +۶ مورد دیگر

Dr. Jan Roelof van der Meer is a full professor at the Faculty of Biology and Medicine , University of Lausanne (UNIL), specializing in environmental microbiology and polluted ecosystems. Since 2012, he has held a professorship while leading the Department of Fundamental Microbiology (DMF) from 2011-2021 and directing the NCCR Microbiomes program since 2020. His research focuses on: Bacterial adaptation and evolutionary processes in polluted environments Genetic mechanisms for horizontal gene transfer Catabolic pathways for degrading chlorinated organic compounds Development of synthetic biology-based biosensors (e.g., arsenic detector patent with Leipzig colleagues) Dynamics of microbial communities under natural selection He has secured significant funding, including four European projects, and his work addresses critical environmental remediation challenges. Awards: 2010 Erwin Schrödinger Prize

Robert Beikoمشاهده پروفایل

استاد

• Bioinformatics
• Comparative Genomics
• Phylogenetics
• +۸ مورد دیگر

Robert Beiko is a Professor in the Faculty of Computer Science at Dalhousie University, where he leads the Beiko Lab in Bioinformatics and is affiliated with the Algorithms & Bioinformatics research cluster. His research focuses on understanding microbial ecosystems through computational methods. Education: PhD, University of Ottawa (2003) BSc, Dalhousie University (1998) His research spans bioinformatics, comparative genomics, phylogenetics, machine learning, and visualization of biological data, with particular emphasis on the human microbiome, antimicrobial resistance, and horizontal gene transfer. His lab utilizes advanced techniques including amplicon sequencing, metagenomics, and machine learning approaches to analyze complex microbial communities. Although no specific publications are listed in the source text, his research output consistently contributes to the fields of computational biology and microbial genomics, with a strong interdisciplinary focus on health and environmental microbiology. He is currently offering fellowship opportunities, indicating active research programs and funding. He teaches courses within the Faculty of Computer Science and mentors students in bioinformatics research. Labs and Research Groups: Beiko's Lab in Bioinformatics Algorithms & Bioinformatics Research Cluster

Heidi M. Mansourمشاهده پروفایل

استاد

• Pharmaceutical Sciences
• Nanotechnology
• Nanomedicine
• +۱۶ مورد دیگر

Dr. Heidi M. Mansour is a tenured Full Professor at Florida International University (FIU), affiliated with the Robert Stempel College of Public Health and Social Work (Department of Environmental Health Sciences), Herbert Wertheim College of Medicine (Department of Cellular and Molecular Medicine), and the College of Engineering (Department of Biomedical Engineering). She leads the Drug Discovery and Delivery Program at the FIU Center for Translational Science in Port Saint Lucie, Florida, and has been a faculty member since February 2022. Research Interests: Dr. Mansour's research spans pharmaceutical sciences, nanotechnology, and translational medicine, with a focus on advanced drug delivery systems. Her work emphasizes inhaled medical aerosols, microparticles, nanoparticles, controlled and sustained release systems, and transdermal delivery. She investigates therapies for cystic fibrosis, pulmonary hypertension, infectious diseases, CNS disorders, and respiratory distress syndromes using both in vitro (2D/3D human cell models, spheroids) and in vivo models. Scientific Recognition: She has been honored with multiple prestigious fellowships: Fellow, American Institute of Medical and Biological Engineering (AIMBE), 2022 Fellow, Royal Society of Chemistry (RSC), 2024 Senior Member, National Academy of Inventors (NAI), 2023 Fellow, American Thoracic Society (ATS), 2025 Fellow, Global Academy of Nanotechnology (GAN), 2025 Fellow, International Academy of Nanotechnology (IAN), 2024 Fellow, Florida Association for Nanotechnology (FAN), 2024 ATS Presidential Commendation, 2024 Grants, Editorial & Advisory Roles: Her research is supported by NIH, FDA, and industry partners. She serves on the PhRMA Foundation Scientific Advisory Committee, ISAM Executive Board, and Cystic Fibrosis Foundation Scientific Advisory Board. She is an Associate Editor of RSC Pharmaceutics and Topics Editor of Pharmaceutics , and serves on editorial boards of multiple journals including Frontiers in Drug Delivery , Current Nanomedicine , and RSC Molecular Systems Design & Engineering . Training & Leadership: Dr. Mansour has mentored 15 postdoctoral scholars and graduated 5 PhD students. She previously served as Director of the PharmD/PhD dual-degree program and Pharmaceutics/Pharmacokinetics Track at the University of Arizona. She has co-edited two major books and published over 130 peer-reviewed articles and 17 book chapters. Laboratory & Conferences: She leads the Mansour Lab , focused on inhalation aerosols and nanomedicine. She is organizing the NanoFlorida 2025 Conference at FIU, highlighting her leadership in the nanotechnology community.

Hillary Egnaمشاهده پروفایل

استاد

• Aquaculture
• Fisheries Science
• Sustainable Development
• +۷ مورد دیگر

Hillary Egna is a Professor and Senior Researcher in the Department of Fisheries, Wildlife, and Conservation Sciences at Oregon State University, affiliated with the College of Agricultural Sciences. She serves as Director of the AquaFish Innovation Lab (formerly CRSP), a major international research initiative funded by USAID, focused on sustainable aquaculture, food security, and poverty reduction in developing countries. Institution: Oregon State University School: College of Agricultural Sciences Department: Fisheries, Wildlife, and Conservation Sciences Role: Professor (Sr Res), Director of AquaFish Innovation Lab Email: hiliary.egna@oregonstate.edu Her research spans aquaculture systems, nutrition-sensitive aquaculture, gender equity, feed optimization, and climate resilience, with fieldwork across Africa and Asia. She has led numerous international projects and trained generations of aquaculture scientists. Her recent publications reflect a strong focus on sustainable aquaculture practices, including Nile tilapia nutrition, mud crab farming in Bangladesh, school-based aquaculture in Nepal, and nutrient-rich fish powder for food-insecure populations. These works highlight her commitment to linking aquaculture with public health, education, and economic development. Scientific Awards and Honors: Honorary Life Award, World Aquaculture Society (2012) Board for International Agriculture and Rural Development (BIFAD) Award for Scientific Excellence (2018) International Service Award, OSU University Day (2021) Faculty Recognition Award, College of Earth, Ocean, and Atmospheric Sciences, OSU (2014) Women in Leadership Award, UNIFEM, United Nations (1997) AFS Gold Medal Award, Asian Fisheries Society (2016) Dr. Egna has advised numerous international projects and mentored researchers across Africa and Asia. She has led large-scale, USAID-funded grants such as the AquaFish Innovation Lab, focusing on capacity building, gender integration, and sustainable development. Her work has significantly advanced the role of aquaculture in food security and rural livelihoods. She leads the AquaFish Innovation Lab, a major international research consortium involving multiple universities and partner countries. Her team conducts interdisciplinary research on aquaculture technologies, value chains, and policy, with strong emphasis on gender equity and climate resilience.

Linda Amaral-Zettlerمشاهده پروفایل

استاد

• Marine Microbiology
• Microbial Ecology
• Environmental Change
• +۱۲ مورد دیگر

Linda Amaral-Zettler is a Professor and Research Leader at the Royal Netherlands Institute for Sea Research (NIOZ), with a Chair in Marine Microbiology at the University of Amsterdam. She leads research in the Microbiology & Biogeochemistry department, focusing on microbial community dynamics in human-impacted and extreme marine environments. Her research interests include: microbial ecology of the Plastisphere , harmful algal blooms (HABs) , fish microbiomes , microbial biogeography , and alkenone-producing haptophytes as paleotemperature proxies. She employs cutting-edge molecular tools such as metagenomics and transcriptomics to study microbial diversity and function across global sites, including the Antarctic Peninsula, Caribbean Sargassum blooms, and microplastic debris. Her recent publications reflect a strong focus on environmental change, marine pollution, and microbial sentinels of ecosystem health. Trends show increasing emphasis on plastic transport of pathogens , climate-driven algal blooms , and deep-ocean microplastic accumulation . ERC Advanced Grant from the European Commission NWO ENW Groot Award (project leader) NWO grant for Sargassum inundations research She has led major research initiatives, including projects on nanoplastics and biodegradable plastics, often in collaboration with international partners. Her work is supported by national and European funding agencies and involves extensive fieldwork aboard research vessels like RV Pelagia. She mentors students and researchers, contributing to graduate education through UvA and NIOZ programs. Linda Amaral-Zettler leads a dynamic research group at NIOZ-Texel, actively involved in projects such as the study of holopelagic Sargassum strandings and the development of genomic tools for tracking microbial communities. Her lab collaborates with organic geochemists at Brown University and participates in international consortia focused on marine ecosystem resilience.

• Cardiology
• Exercise Physiology
• Cardiac Rehabilitation
• +۵ مورد دیگر

Dr. David Holland serves as an Honorary Associate Professor in the School of Human Movement and Nutrition Sciences at the University of Queensland. His academic career spans over 15 years with extensive research contributions in cardiology, exercise physiology, and cardiac rehabilitation. His work bridges clinical cardiology with exercise science, focusing on improving outcomes for patients with cardiovascular conditions. Dr. Holland's primary research interests center around cardiac rehabilitation, particularly high-intensity interval training (HIIT) protocols for coronary heart disease patients. His work examines exercise physiology, cardiovascular imaging, heart failure with preserved ejection fraction (HFpEF), atrial fibrillation, and the cardiovascular effects of diabetes. He has made significant contributions to understanding how exercise impacts vascular function, cardiac imaging parameters, and patient outcomes in cardiac rehabilitation settings. His recent publication trends show a strong focus on clinical applications of exercise physiology in cardiac rehabilitation, with particular emphasis on high-intensity interval training protocols. His research spans from basic cardiovascular physiology to clinical trials, with notable work on the FITR Heart Study. His publications cover diverse areas including echocardiography, cardiac complications of medical conditions, and the intersection of exercise science with cardiology. Dr. Holland has collaborated extensively with researchers across cardiology, exercise physiology, and nutrition science. His work often involves multidisciplinary teams examining the relationship between exercise, cardiac function, and patient outcomes. While specific grants aren't detailed in the provided information, his research program appears well-established with numerous clinical studies and collaborations with major cardiac research groups. His laboratory and research team work appears centered around the FITR Heart Study and related cardiac rehabilitation research. He collaborates closely with exercise physiologists, cardiologists, and imaging specialists to investigate how different exercise protocols affect cardiovascular function and patient outcomes in cardiac rehabilitation settings.

• Metabolomics
• Systems Biology
• Alzheimer's Disease Research
• +۶ مورد دیگر

Jan Krumsiek is an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences, affiliated with both the Physiology, Biophysics & Systems Biology and Computational Biology programs. His research sits at the intersection of metabolism, computational biology, and disease mechanisms. Dr. Krumsiek's research focuses on how metabolism shapes health and disease across multiple conditions including neurodegeneration, cancer, and cardiometabolic disorders. His lab integrates metabolomics, proteomics, transcriptomics, and genomics with computational analysis to reveal actionable biomarkers and elucidate molecular mechanisms. Key ongoing projects investigate tau-related metabolic disruptions in Alzheimer's disease, the impact of dietary interventions on brain health, tumor escape pathways in resistant lymphomas via spatial metabolomics, and microbial biosynthetic clusters as therapeutic opportunities. The lab also utilizes large-scale NMR-based approaches to refine cardiometabolic risk models and investigate metabolic signatures tied to clinical outcomes in conditions like COVID-19. Analysis of Dr. Krumsiek's recent publications (2023-2025) reveals a strong focus on Alzheimer's disease metabolism, with numerous studies examining how dietary interventions, particularly modified Mediterranean ketogenic diets, affect metabolic signatures in neurodegenerative conditions. His work also spans cancer metabolism, space medicine omics, and multi-omics integration methodologies. A notable trend is the application of computational frameworks to analyze complex metabolic data across different disease states and interventions. Dr. Krumsiek leads the Krumsiek Lab, which employs a multidisciplinary approach combining wet-lab metabolomics techniques with advanced computational analysis. The lab's work spans from basic metabolic pathway analysis to clinical applications, with particular emphasis on translating metabolic findings into potential therapeutic interventions.

Melissa Cushingمشاهده پروفایل

استاد بالینی

• Transfusion Medicine
• Laboratory Medicine
• Hematology
• +۳ مورد دیگر

Melissa Cushing, M.D., is a Clinical Professor in the Department of Pathology and Laboratory Medicine at Weill Cornell Medical College. She serves as Executive Vice Chair for Clinical Affairs, Medical Director of Clinical Laboratories, and Division Director of Transfusion Medicine and Cellular Therapy at Weill Cornell Medical College and NewYork-Presbyterian Hospital. M.D. from Georgetown University School of Medicine (2001) Clinical Pathology Residency at Emory University School of Medicine (2005) Fellowship in Transfusion Medicine and Cellular Therapy at Johns Hopkins School of Medicine (2006) Her research focuses on transfusion medicine, coagulation management, and laboratory medicine with particular emphasis on COVID-19 diagnostics , pathogen-reduced blood products , and perioperative hemostasis . Recent publications examine SARS-CoV-2 testing strategies, fibrinogen replacement therapies, and blood product inventory systems. Her work bridges clinical pathology with anesthesiology through cross-departmental collaborations. Dr. Cushing holds dual board certifications in Clinical Pathology and Blood Banking/Transfusion Medicine from the American Board of Pathology. She actively collaborates with industry partners including: Ceruus Corporation (Scientific Advisory Board) CSL Behring & Octapharma (Consultancy roles) Grifols & Werfen (Research Partnerships) Her 15 most recent articles (2023-2025) demonstrate expertise in transfusion safety , coagulopathy management , and innovative blood product applications across specialties including anesthesiology, critical care, and infectious diseases.

• Biomedical Research
• Physical Chemistry
• Analytical Chemistry
• +۷ مورد دیگر

Mayland Chang is a Research Professor in the Department of Chemistry and Biochemistry at the University of Notre Dame, within the College of Science. Her research spans biomedical chemistry, focusing on therapeutic interventions for chronic diseases and antibiotic-resistant infections. Research Interests: Understanding the molecular basis of diabetic wound healing through matrix metalloproteinase (MMP) activity, particularly MMP-8 and MMP-9. Designing novel small-molecule therapeutics such as ND-336 for diabetic foot ulcers. Developing new classes of antibiotics including quinazolinones and oxadiazoles to combat MRSA and Clostridioides difficile . Targeting bacterial resistance mechanisms, especially PBP2a in MRSA and spore germination pathways in C. difficile . The recent publications show a consistent trend in targeting pathogenic mechanisms at the molecular level, combining quantitative proteomics, enzyme kinetics, and in vivo evaluation. Her work bridges chemistry and translational medicine, aiming to deliver clinically relevant therapeutics. Scientific Leadership: Director, CBBI Program (2007–2022) Dr. Chang mentors graduate students and welcomes prospective applicants to join her lab. She has secured long-term research funding enabling sustained projects in antibiotic development and wound healing. Her collaborative work with Prof. Shahriar Mobashery highlights a strong interdisciplinary team approach. She is actively involved in cutting-edge research with ongoing projects identifying active MMPs in diabetic patients and optimizing oxadiazole compounds for C. difficile treatment.

• Obesity
• Gestational Diabetes
• Pediatric Nursing
• +۲ مورد دیگر

Montana Robertson serves as Assistant Professor in the Department of Prelicensure Nursing at Augusta University's College of Nursing, leveraging 25 years of clinical nursing experience including 15 years in pediatric intensive care (PICU) and nine years as a nurse educator for prelicensure students. Education: Ph.D. in Registered Nursing, Augusta University (2022) MSN in Registered Nursing, Walden University (2013) AAS in Nursing, Chattahoochee Valley Community College (1998) Research Focus: Dr. Robertson investigates maternal obesity and gestational diabetes impacts on infant health, particularly examining gut microbiome development and pediatric blood pressure patterns . Her work bridges clinical pediatric nursing with preventive health strategies for at-risk populations. Publication Profile: Her 2020 research demonstrates consistent focus on maternal metabolic conditions and infant outcomes, establishing a trajectory in microbiome-related pediatric nursing science with implications for early-life intervention protocols. Academic Leadership: Faculty Advisor for Augusta University Student Nurses Association (AU-SNA) since 2017 BSN Admissions Committee Member since 2017 College of Nursing Quality Plan Committee Member since 2017 Educational Impact: Teaches core courses including NURS 7400 (Integrated Health Care for Women/Child Family Health), NURS 3807 (Nursing Research), NURS 4802 (Maternal Child Nursing), and NURS 3802 (Nursing Practice), with specialized expertise in pediatric nursing education and clinical research methodology.

Lisa Klassonمشاهده پروفایل

مدرس ارشد

• Evolutionary Biology
• Comparative Genomics
• Symbiosis
• +۳ مورد دیگر

Lisa Klasson serves as Senior Lecturer at Uppsala University's Department of Cell and Molecular Biology, where she leads research in microbial genomics and evolutionary biology. She currently directs the Master's program in Bioinformatics, bridging computational and biological sciences. Her research focuses on comparative genomics of insect-associated bacterial symbionts , particularly Wolbachia and Coxiella, investigating evolutionary forces shaping host-symbiont interactions. Using whole genome sequencing , transcriptomics , and comparative genomic analyses , she examines genome reduction mechanisms, horizontal gene transfer, and symbiont-induced speciation phenomena. Key interests include Wolbachia's role in cytoplasmic incompatibility, endosymbiont genome stability after host transfers, and evolutionary transitions along the parasitism-mutualism continuum. Analysis of her 15 most recent publications reveals dominant themes in Drosophila-Wolbachia coevolution (73% of works), with significant contributions to understanding mitochondrial introgression (2023), genome expansion exceptions (2019), and reticulate evolution (2024). Her work consistently employs advanced genomic methodologies to dissect symbiotic mechanisms across evolutionary timescales. Lisa actively contributes to academic leadership as Program Director for the Bioinformatics Master's program, shaping next-generation genomic scientists. Her collaborative research spans international institutions, with frequent co-authorship with Drosophila and symbiosis specialists. Her laboratory investigates evolutionary impacts of symbionts on host genomes through transcriptomic and genomic approaches, maintaining focus on Wolbachia-Drosophila systems while expanding to Coxiella-tick models. Current projects include analyzing horizontal gene transfer dynamics and symbiont-mediated speciation mechanisms.